Effect of atorvastatin on expression of TLR4 and NF-κB p65 in atherosclerotic rabbits.

[1]  N. Schneiderman,et al.  Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. , 2012, JAMA.

[2]  A. Majluf-Cruz,et al.  Protein C activation peptide inhibits the expression of ICAM-1, VCAM-1, and interleukin-8 induced by TNF-a in human dermal microvascular endothelial cells , 2012 .

[3]  Michael C. McDaniel,et al.  Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function. , 2012, The Journal of invasive cardiology.

[4]  D. Mikhailidis,et al.  Send Orders of Reprints at Reprints@benthamscience.org Patient with Hypertriglyceridemia, Type 2 Diabetes, and Chronic Kidney Disease Treated with Atorvastatin and Omega-3 Fatty Acid Ethyl Esters , 2022 .

[5]  M. Gawaz,et al.  Macrophage Migration Inhibitory Factor Is Enhanced in Acute Coronary Syndromes and Is Associated with the Inflammatory Response , 2012, PloS one.

[6]  R. Balaraman,et al.  Tomato lycopene attenuates myocardial infarction induced by isoproterenol: electrocardiographic, biochemical and anti-apoptotic study. , 2012, Asian Pacific journal of tropical biomedicine.

[7]  A. Majluf-Cruz,et al.  Protein C activation peptide inhibits the expression of ICAM-1, VCAM-1, and interleukin-8 induced by TNF-α in human dermal microvascular endothelial cells. , 2012, Folia histochemica et cytobiologica.

[8]  D. J. Taur,et al.  Some medicinal plants with antiasthmatic potential: a current status. , 2011, Asian Pacific journal of tropical biomedicine.

[9]  Arun Kumar,et al.  Lipid ratio useful indicator in predicting risk of myocardial infarction in elderly normolipidemic patients: a report from a multi center study , 2011 .

[10]  C. Cannon,et al.  Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study). , 2009, The American journal of cardiology.

[11]  V. Brusasco,et al.  Review: Airway smooth muscle as a model for new investigative drugs in asthma , 2008, Therapeutic advances in respiratory disease.